- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 33/243 - Platinum; Compounds thereof
Patent holdings for IPC class A61K 33/243
Total number of patents in this class: 977
10-year publication summary
3
|
3
|
12
|
19
|
104
|
152
|
195
|
213
|
165
|
47
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Imam Abdulrahman Bin Faisal University | 343 |
14 |
AstraZeneca AB | 3042 |
12 |
Board of Regents, The University of Texas System | 5370 |
12 |
Mayo Foundation for Medical Education and Research | 2981 |
11 |
Inserm (institut National de La Sante et de La Recherche Medicale) | 3314 |
11 |
The Regents of the University of California | 18943 |
9 |
Dana-Farber Cancer Institute, Inc. | 2455 |
9 |
Fennec Pharmaceuticals Inc. | 20 |
9 |
Genentech, Inc. | 3742 |
8 |
Arcus Biosciences, Inc. | 107 |
8 |
Bristol-myers Squibb Company | 5080 |
7 |
The Cleveland Clinic Foundation | 1591 |
7 |
Crititech, Inc. | 76 |
7 |
Eli Lilly and Company | 3645 |
7 |
ADS Pharma Consulting, LLC | 7 |
7 |
Duke University | 2872 |
6 |
Indiana University Research and Technology Corporation | 808 |
6 |
Taisho Pharmaceutical Co., Ltd. | 844 |
6 |
Centre National de La Recherche Scientifique | 9632 |
5 |
The Johns Hopkins University | 5377 |
5 |
Other owners | 811 |